Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Clinical trial NCT02323659 · TERMINATED

Trial details

NCT number: NCT02323659
Sponsor: Polish Lymphoma Research Group
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Cutaneous Mycosis Fungoides

Start date: 2014-06-01
Primary completion: 2018-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.